Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Liberia
Liberia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 80.0% in 2024. ▲ Rising
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Liberia, 2014–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
Liberia recorded 80.0% for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in 2024. That is the highest value across all 11 years on record.
The figure is up 220.0% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Liberia peaked at 80.0% in 2023 and was at its lowest, 25.0%, in 2014.
Liberia ranks 104th of 146 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 11 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Liberia, year by year
| Year | % | Change |
|---|---|---|
| 2014 | 25.0% | — |
| 2015 | 36.0% | +44.0% |
| 2016 | 73.0% | +102.8% |
| 2017 | 78.0% | +6.8% |
| 2018 | 78.0% | +0.0% |
| 2019 | 68.0% | -12.8% |
| 2020 | 65.0% | -4.4% |
| 2021 | 65.0% | +0.0% |
| 2022 | 74.0% | +13.8% |
| 2023 | 80.0% | +8.1% |
| 2024 | 80.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 59.7% | 25.0% | 78.0% | 6 |
| 2020s | 72.8% | 65.0% | 80.0% | 5 |
Countries ranked near Liberia
More health data for Liberia
- Un projection of annual infant deaths, annual growth rate -1.57 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7528 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,097 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,457 deaths (2100)
- Population ages 0-14, female, annual growth rate 0.9448 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1929 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.9526 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1979 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Liberia?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Liberia was 80.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Liberia?
- The highest recorded value was 80.0% in 2023.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Liberia?
- The lowest recorded value was 25.0% in 2014.
- How does Liberia rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Liberia ranks 104th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Liberia?
- Over the last ten years it is up 220.0%. The long-run trend across the full record is rising.
- Where does this Liberia data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.